Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,209 | -42,309 | -42,876 | -16,616 | -17,014 |
| Depreciation Amortization | 1,448 | 546 | 219 | 93 | 240 |
| Accounts receivable | -1,693 | 6 | 2,092 | 2,622 | -2,796 |
| Accounts payable and accrued liabilities | 1,537 | 2,209 | 893 | 1,018 | 1,681 |
| Other Working Capital | 158,064 | 168,208 | 186,960 | -1,870 | 37,651 |
| Other Operating Activity | 34,663 | 29,094 | 26,437 | 6,282 | -397 |
| Operating Cash Flow | $154,810 | $157,754 | $173,725 | $-8,471 | $19,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,174 | -1,816 | -1,165 | -314 | -782 |
| Net Acquisitions | -14,321 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -359,378 | -267,513 | 0 | N/A | N/A |
| Sale Of Investment | 77,885 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-297,988 | $-269,329 | $-1,165 | $-314 | $-782 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 308 |
| Debt Repayment | N/A | N/A | N/A | N/A | -200 |
| Common Stock Issued | 151,656 | 150,588 | 151,329 | 88 | 49 |
| Other Financing Activity | 22,522 | 22,522 | 22,522 | 22,225 | 92,184 |
| Financing Cash Flow | $174,178 | $173,110 | $173,851 | $22,313 | $92,341 |
| Beginning Cash Position | 119,456 | 119,456 | 119,456 | 119,456 | 8,532 |
| End Cash Position | 150,456 | 180,991 | 465,867 | 132,984 | 119,456 |
| Net Cash Flow | $31,000 | $61,535 | $346,411 | $13,528 | $110,924 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,810 | 157,754 | 173,725 | -8,471 | 19,365 |
| Capital Expenditure | -2,174 | -1,816 | -1,165 | -314 | -782 |
| Free Cash Flow | 152,636 | 155,938 | 172,560 | -8,785 | 18,583 |